FIELD: pharmaceuticals.
SUBSTANCE: invention relates to cytotoxic dimers containing CBI and / or CPI-based subunits, antibody-drug conjugates containing such dimers and methods for using the same to treat cancer and other conditions.
EFFECT: bifunctional cytotoxic agents are prorosed.
28 cl, 9 tbl, 324 ex
Title | Year | Author | Number |
---|---|---|---|
CYTOTOXIC PEPTIDES AND ANTIBODY-DRUG CONJUGATES THEREOF | 2012 |
|
RU2586885C2 |
BIFUNCTION CYTOTOXIC AGENTS CONTAINING PHARMACOPHORE CTI | 2016 |
|
RU2682645C1 |
CALICHEAMICIN DERIVATIVES AND THEIR ANTIBODY-DRUG CONJUGATES | 2018 |
|
RU2732568C1 |
ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2632193C2 |
PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2014 |
|
RU2708395C2 |
HETEROCYCLIC COMPOUNDS, EFFECTIVE FOR KINASE INHIBITION | 2011 |
|
RU2640862C2 |
SPLICEOSTATIN ANALOGS | 2013 |
|
RU2618523C2 |
DELAYED-RELEASE DELIVERY SYSTEMS CONTAINING TRACELESS LINKERS | 2018 |
|
RU2772690C2 |
SPIROPIPERIDINES, METHODS OF THEIR SYNTHESIS (VARIANTS) | 1993 |
|
RU2168512C2 |
IMIDAZOPYRIDINE DERIVATIVE USED IN TREATMENT OF DIABETES | 2013 |
|
RU2648242C2 |
Authors
Dates
2018-10-16—Published
2015-01-14—Filed